US FDA authorizes Pfizer-BioNTech, Moderna's updated Covid shots
India TodayThe U.S. Food and Drug Administration on Monday authorized updated Covid-19 vaccines from Pfizer/BioNTech and Moderna that target a recently circulating Omicron variant of the coronavirus, paving the way for the launch later this week of a fall vaccination campaign. Pfizer and Moderna said their updated vaccines, which target the XBB.1.5 subvariant of the virus, were expected to be available for most people in the United States in the coming days. "The public can be assured that these updated vaccines have met the agency's rigorous scientific standards for safety, effectiveness and manufacturing quality," top FDA scientist Dr. Peter Marks said in a statement. Pfizer and Moderna said last week that their updated Covid -19 vaccines generated strong responses in testing against BA.2.86. Novavax is still working to see how effective its vaccine is against the subvariant, the company's Chief Executive John Jacobs said in an interview.